Safety Evaluation of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation
Clinical trial NCT03002519 · COMPLETED
Trial details
- NCT number
- NCT03002519
- Sponsor
- Pluristem Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-08
- Primary completion
- 2021-09-30
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.